收藏切换
Determination of Adalimumab in Human Plasma by Immuno-Affinity Enrichment and UPLC-Q Exactive-Orbitrap MS
收藏切换
PDF
Xiaoliang DING1, 2, Shengxiong ZHU1, 2, Linsheng LIU1, 2, Xiaoxue LIU1, 2, Liyan MIAO1, 2, *
Chinese Pharmaceutical Journal | 2025, 60(1) : 71 - 76
Less
收藏切换
Chinese Pharmaceutical Journal | 2025, 60(1): 71-76
Determination of Adalimumab in Human Plasma by Immuno-Affinity Enrichment and UPLC-Q Exactive-Orbitrap MS
Full
Xiaoliang DING1, 2, Shengxiong ZHU1, 2, Linsheng LIU1, 2, Xiaoxue LIU1, 2, Liyan MIAO1, 2, *
Affiliations
  • 1 Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou 215006,China
  • 2 Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou 215006, China
Published: 2025-01-08 doi: 10.11669/cpj.2025.01.009
Outline
收藏切换

OBJECTIVE To establish an efficient method for quantification of adalimumab in human plasma based on UPLC-Q Exactive-Orbitrap MS platform combined with immuno-affinity enrichment strategy. METHODS Candidate surrogate peptides were screened by full MS/ddMS2 and the selective surrogate peptide was quantitatively analyzed by parallel reaction monitoring. Immunoglobulins and therapeutic antibodies in human plasma were extracted by magnetic beads coupled with protein A. The proteins were denatured at high temperature and digested by trypsin. Stable-isotope labeled adalimumab was used as internal standard. RESULTS The peptide GLEWVSAITWNSGHIDYADSVEGR in variable region of adalimumab heavy chain was selected as signature peptide, showing specificity and selectivity. Adalimumab demonstrated good correlation within the range of 1-32 μg·mL-1. Precision, accuracy and total error all met the verification requirements. Thirty-one clinical samples had measurable adalimumab concentrations by the established method and ELISA method, yielding a good correlation. The mean of difference between the two methods was 0.5 μg·mL-1. CONCLUSION The universal immuno-affinity mass spectrometry method established in the study is suitable for quantification of therapeutic antibodies, and can accurately and precisely determine adalimumab concentration, which provides a strategy for clinical monitoring.

adalimumab  /  mass spectrum  /  therapeutic drug monitoring
Xiaoliang DING, Shengxiong ZHU, Linsheng LIU, Xiaoxue LIU, Liyan MIAO. Determination of Adalimumab in Human Plasma by Immuno-Affinity Enrichment and UPLC-Q Exactive-Orbitrap MS[J]. Chinese Pharmaceutical Journal, 2025 , 60 (1) : 71 -76 . DOI: 10.11669/cpj.2025.01.009
Year 2025 volume 60 Issue 1
PDF
145
57
Cite this Article
BibTeX
Article Info
doi: 10.11669/cpj.2025.01.009
  • Receive Date:2024-05-15
  • Online Date:2025-11-24
  • Published:2025-01-08
Article Data
Affiliations
History
  • Received:2024-05-15
Funding
Affiliations
    1 Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou 215006,China
    2 Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou 215006, China
References
Share
https://castjournals.cast.org.cn/joweb/zgyxzz/EN/10.11669/cpj.2025.01.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT